Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8491 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8477 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8428 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8411 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8389 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8375 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8204 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8188 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD1933 |
Approved |
0.8129 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8098 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8057 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8047 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8036 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8036 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8012 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7988 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7953 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7937 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7927 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7895 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7871 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7852 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7849 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7785 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7771 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7751 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7719 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD411 |
Approved |
0.7712 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7707 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7683 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7636 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7614 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.761 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7544 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7542 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD919 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD3267 |
Approved |
0.75 |
Intermediate Similarity |
NPD943 |
Approved |
0.75 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7486 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7439 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7439 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7421 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7403 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7389 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7386 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7381 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7381 |
Intermediate Similarity |
NPD5889 |
Approved |
0.738 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7354 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7301 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7284 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7257 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7246 |
Intermediate Similarity |
NPD920 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7207 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD1613 |
Approved |
0.717 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7167 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7161 |
Intermediate Similarity |
NPD1470 |
Approved |
0.716 |
Intermediate Similarity |
NPD5405 |
Approved |
0.716 |
Intermediate Similarity |
NPD5406 |
Approved |
0.716 |
Intermediate Similarity |
NPD5408 |
Approved |
0.716 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7135 |
Intermediate Similarity |
NPD37 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD1611 |
Approved |
0.712 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD4966 |
Approved |
0.711 |
Intermediate Similarity |
NPD4965 |
Approved |
0.711 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7053 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7048 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7013 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7006 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7006 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5710 |
Approved |
0.6994 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6994 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6988 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD6273 |
Approved |
0.697 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6966 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6951
|
Remote Similarity |
NPD2438 |
Suspended |